The EU AI Act is not just a compliance issue — it’s a strategic point for every pharma and healthcare leader using AI.
With enforcement beginning in 2026, the Act classifies most healthcare AI systems — from clinical decision support tools to AI-powered medical devices — as “high-risk”, triggering new and intensive requirements: transparency, data integrity, human oversight, and continuous monitoring.
Download this deep-dive analysis to understand:
Now is the time to act. This guide breaks down what the EU AI Act means for your organisation, what will be required to comply, and how early preparation can turn regulatory pressure into a strategic advantage.